Kestra Advisory Services, LLC

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1830819 AUSTIN, TX

Position in PLX

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$23,300

+$1,600 QoQ

Shares Held

10,000

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 101 holders

Holding Since

Jun 2023

12 quarters on record

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. PLX ranks #48 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,732	$7,814,556
2	REGN	Regeneron Pharmaceuticals, Inc.	2,893	$1,803,901
3	RPRX	Royalty Pharma plc	27,331	$1,532,449
4	CPRX	Catalyst Pharmaceuticals, Inc.	39,421	$1,239,002
5	VKTX	Viking Therapeutics, Inc.	27,091	$1,056,819
6	IBRX	ImmunityBio, Inc.	110,630	$968,565
7	CORT	Corcept Therapeutics Inc	10,914	$948,972
8	CRSP	CRISPR Therapeutics AG	17,292	$943,105

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,300	10,000	0.0%	Shares	Sole	2026-07-28
2026-03-31	$21,700	10,000	0.0%	Shares	Sole	2026-04-30
2025-12-31	$18,000	10,000	-9.1%	Shares	Sole	2026-02-13
2025-09-30	$24,420	11,000	-75.3%	Shares	Sole	2025-11-14
2025-03-31	$113,920	44,500	+217.9%	Shares	Sole	2025-05-14
2024-12-31	$26,320	14,000	-12.5%	Shares	Sole	2025-02-10
2024-09-30	$16,320	16,000	0.0%	Shares	Sole	2024-11-13
2024-06-30	$18,720	16,000	0.0%	Shares	Sole	2024-08-14
2024-03-31	$20,160	16,000	+39.1%	Shares	Sole	2024-05-15
2023-12-31	$20,470	11,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$19,090	11,500	0.0%	Shares	Sole	2023-11-13
2023-06-30	$23,000	11,500	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.